New Drug Update – Repatha (Evolocumab)
Update on Repatha (Evolocumab) - a Medication Used to Treat High Low Density Lipoprotein CholesterolApproved by the FDA in August 2015, Repatha (Evolocumab) is a subcutaneous injection used to [...]
Fluoroquinolones Restrictions from FDA
FDA Recommends Restricting the Use of Fluoroquinolones Due to Potential Side EffectsThe FDA has recently released a statement indicating that the use of systemic fluoroquinolones should be [...]
Evidence-based Approaches to Gradual Dose Reductions of Antipsychotic Drugs
The use of antipsychotic drugs for the management of the Behavioral and Psychological Symptoms of Dementia (BPSD) is not an FDA-approved indication, is controversial, and yet continues to be [...]
What’s All the Fuss about Antipsychotic Use
Before a prescription drug manufacturer can promote a medication for a specific indication they must conduct extensive clinical trials demonstrating safety and effectiveness. The FDA (Food and [...]
